Regulation of Cellular Heterogeneity and Rates of Symmetric and Asymmetric Divisions in Triple-Negative Breast Cancer
Differentiation events contribute to phenotypic cellular heterogeneity within tumors and influence disease progression and response to therapy. Here, we dissect mechanisms controlling intratumoral heterogeneity within triple-negative basal-like breast cancers. Tumor cells expressing the cytokeratin...
Main Authors: | Granit, Roy Z., Masury, Hadas, Condiotti, Reba, Fixler, Yaakov, Gabai, Yael, Glikman, Tzofia, Winter, Eitan, Nevo, Yuval, Carmon, Einat, Sella, Tamar, Sonnenblick, Amir, Peretz, Tamar, Lehmann, Ulrich, Paz, Keren, Piccioni, Federica, Ben-Porath, Ittai, Dalin, Simona, Regev, Aviv, Root, David |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Published: |
Elsevier
2018
|
Online Access: | http://hdl.handle.net/1721.1/118749 https://orcid.org/0000-0001-5024-9718 https://orcid.org/0000-0001-8567-2049 |
Similar Items
-
Regulation of Cellular Heterogeneity and Rates of Symmetric and Asymmetric Divisions in Triple-Negative Breast Cancer
by: Roy Z. Granit, et al.
Published: (2018-09-01) -
EZH2 promotes a bi-lineage identity in basal-like breast cancer cells
by: Granit, R. Z., et al.
Published: (2013) -
“High-Risk Breast Cancer Screening in BRCA1/2 Carriers Leads to Early Detection and Improved Survival After a Breast Cancer Diagnosis”
by: Shay Shraga, et al.
Published: (2021-09-01) -
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer
by: Alkhatib, Heba, et al.
Published: (2024) -
Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin
by: Avital Granit, et al.
Published: (2022-12-01)